Inflammasome Proteins in Cerebrospinal Fluid of Patients with Subarachnoid Hemorrhage are Biomarkers of Early Brain Injury and Functional Outcome
- PMID: 27443226
- DOI: 10.1016/j.wneu.2016.07.039
Inflammasome Proteins in Cerebrospinal Fluid of Patients with Subarachnoid Hemorrhage are Biomarkers of Early Brain Injury and Functional Outcome
Abstract
Background: Aneurysmal subarachnoid hemorrhage (SAH) remains a devastating disease with significant morbidity and mortality. To date, clinical variables are still used to evaluate injury severity and prognosis. This study was designed to investigate the role of cerebrospinal fluid (CSF) inflammasome proteins as laboratory-based biomarkers of brain injury severity and outcome in SAH patients.
Methods: Ten control patients and 24 SAH patients were prospectively enrolled in this study. CSF samples were collected within 72 hours after SAH. Levels of inflammasome proteins in the CSF, including NLRP1, ASC, and caspase-1 were analyzed.
Results: Immunoblot analysis exhibited that levels of NLRP1, ASC and caspase-1 were elevated in the CSF of SAH patients (P < 0.0001, P = 0.0178, and P < 0.0001, respectively). In the group of SAH patients, these inflammasome proteins were significantly higher in the patients with cerebral edema on computed tomographic scans (P = 0.0002, P = 0.0005, and P = 0.0004, respectively), and in the patients with acute hydrocephalus (P = 0.0009, P = 0.00017, and P = 0.0016, respectively). Higher levels of inflammasome proteins were associated with severe SAH and poor outcome 3 months after the SAH. High level of NLRP1 was the independent risk factor of poor outcome after SAH (P = 0.049, odds ratio = 1.730).
Conclusions: Inflammasome proteins are potential biomarkers to assess early brain injury and to predict functional outcome after SAH.
Keywords: Biomarkers; Inflammasome; Subarachnoid hemorrhage.
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Elevated Cerebrospinal Fluid Protein Is Associated with Unfavorable Functional Outcome in Spontaneous Subarachnoid Hemorrhage.J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104605. doi: 10.1016/j.jstrokecerebrovasdis.2019.104605. Epub 2020 Jan 11. J Stroke Cerebrovasc Dis. 2020. PMID: 31932209 Free PMC article.
-
Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article.J Neurosurg. 2012 Dec;117(6):1119-25. doi: 10.3171/2012.9.JNS12815. Epub 2012 Oct 12. J Neurosurg. 2012. PMID: 23061392 Free PMC article.
-
Prognostic value of intrathecal heme oxygenase-1 concentration in patients with Fisher Grade III aneurysmal subarachnoid hemorrhage.J Neurosurg. 2014 Dec;121(6):1388-93. doi: 10.3171/2014.7.JNS131704. Epub 2014 Oct 3. J Neurosurg. 2014. PMID: 25280089
-
Emerging Markers of Early Brain Injury and Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage.World Neurosurg. 2017 Nov;107:148-159. doi: 10.1016/j.wneu.2017.07.114. Epub 2017 Jul 27. World Neurosurg. 2017. PMID: 28755916 Review.
-
A new perspective on cerebrospinal fluid dynamics after subarachnoid hemorrhage: From normal physiology to pathophysiological changes.J Cereb Blood Flow Metab. 2022 Apr;42(4):543-558. doi: 10.1177/0271678X211045748. Epub 2021 Nov 22. J Cereb Blood Flow Metab. 2022. PMID: 34806932 Free PMC article. Review.
Cited by
-
Caspase-1: A Promising Target for Preserving Blood-Brain Barrier Integrity in Acute Stroke.Front Mol Neurosci. 2022 Mar 18;15:856372. doi: 10.3389/fnmol.2022.856372. eCollection 2022. Front Mol Neurosci. 2022. PMID: 35370546 Free PMC article. Review.
-
What do we know about the inflammasome in humans?Brain Pathol. 2017 Mar;27(2):192-204. doi: 10.1111/bpa.12479. Brain Pathol. 2017. PMID: 27997042 Free PMC article. Review.
-
Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases.J Neuroinflammation. 2022 Dec 28;19(1):315. doi: 10.1186/s12974-022-02682-w. J Neuroinflammation. 2022. PMID: 36577999 Free PMC article.
-
TLR4-Pathway-Associated Biomarkers in Subarachnoid Hemorrhage (SAH): Potential Targets for Future Anti-Inflammatory Therapies.Int J Mol Sci. 2022 Oct 20;23(20):12618. doi: 10.3390/ijms232012618. Int J Mol Sci. 2022. PMID: 36293468 Free PMC article. Review.
-
Canonical and non-canonical functions of NLRP3.J Adv Res. 2023 Nov;53:137-151. doi: 10.1016/j.jare.2023.01.001. Epub 2023 Jan 4. J Adv Res. 2023. PMID: 36610670 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous